ExecutiveOrdersEO
EO 14437Executive OrderTrump 47 · R

Executive Order 14437

Advancing Women's Health To Improve Outcomes in All Phases of Life

HealthcareHealthcareFederal WorkforceFederal WorkforceDemocracy & GovernanceDemocracy & Governance

In simple terms

This executive order establishes a new Women's Health Division within the NIH and a White House Women's Health Task Force to coordinate federal research and clinical translation for women's health across all life stages. It revokes two Biden administration actions on women's health research, replacing them with a reorganized structure emphasizing research translation into clinical practice.

Federal Register Open PDF 91 FR 66779

Record & deadlines

  1. Signed

    Signed by the President

  2. FR published

    Published in the Federal Register · 91 FR 66779

    Federal Register PDF

  3. Establishment of Women's Health Division within NIH

Key directives

  • Secretary of HHS shall establish Women's Health Division within NIH within 90 days
  • Women's Health Division shall coordinate with NIH Office of Research on Women's Health on seven specified functions
  • White House Women's Health Task Force co-chaired by HHS Secretary and White House Chief of Staff
  • Task Force shall pursue comprehensive approach across life stages with four focus areas
  • HHS shall provide funding for Task Force administrative costs
  • Revocation of EO 14120 (March 18, 2024)
  • Revocation of Presidential Memorandum of November 13, 2023

Who is ordered

Prior policyRollback

  • revokeExecutive Order 14120 of March 18, 2024 (Advancing Women's Health Research and Innovation)
  • revokePresidential Memorandum of November 13, 2023 (White House Initiative on Women's Health Research)

Related orders

What to expect

Immediate

  • Revocation of EO 14120 and November 2023 Presidential Memorandum
  • Establishment of White House Women's Health Task Force

Near term (90d)

  • Women's Health Division must be established within NIH within 90 days
  • Task Force begins coordination across federal agencies

Long term

  • Research translation into clinical practice and public health implementation
  • Potential pilot programs for integrated care
  • Updated clinical education and provider training

Risks & tensions

  • Revocation of prior administration's women's health structures may create transition disruption
  • Task Force includes unusually broad membership (12+ agencies) which may slow coordination or create jurisdictional friction
  • No new appropriations authorized; implementation 'subject to availability of appropriations' may limit scope
  • Vague 'as deemed appropriate by the agency head' language on pilot programs reduces binding commitment
  • Emphasis on 'translation' over basic research may shift NIH portfolio priorities
Executive Order 14437: Advancing Women's Health To Improve Outcomes in All Phases of Life · Executive Orders